Ernexa Therapeutics (ERNAW) Operating Margin Growth (1y) (2011 - 2024)
Powered by 
Analysis
Ernexa Therapeutics (ERNAW) Operating Margin Growth (1y) (2011 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7,666.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,238.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2,002.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -1,651.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,091.00 |
| 10 | Ernexa Therapeutics | 67,312.70 | 67,312.70 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -242,943.00 |
| Sep 30, 2024 | 1.03 Mn |
| Dec 31, 2020 | -16,406.00 |
| Sep 30, 2020 | -12,902.00 |
| Mar 31, 2020 | -3,789.00 |
| Dec 31, 2019 | -2,667.00 |
| Sep 30, 2019 | -1,306.00 |
| Jun 30, 2019 | 44.00 |
| Mar 31, 2019 | 94.00 |
| Dec 31, 2018 | 1,216.00 |
| Sep 30, 2018 | 718.00 |
| Jun 30, 2018 | -1.00 |
| Mar 31, 2018 | 1,051.00 |
| Dec 31, 2017 | -422.00 |
| Sep 30, 2017 | 659.00 |
| Jun 30, 2017 | 1,240.00 |
| Mar 31, 2017 | -11.00 |
| Dec 31, 2016 | 883.00 |
| Sep 30, 2016 | 1,401.00 |
| Jun 30, 2016 | 2,704.00 |